0001969223-24-000010.txt : 20240119 0001969223-24-000010.hdr.sgml : 20240119 20240119150442 ACCESSION NUMBER: 0001969223-24-000010 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 24545309 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Deignan Charles A. CENTRAL INDEX KEY: 0001664690 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O CLEARSIDE BIOMEDICAL, INC. STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30005 144 1 primary_doc.xml 144 0001664690 XXXXXXXX LIVE 0001539029 Clearside Biomedical 001-37783 900 N Point Parkway Ste 200 Alpharetta GA 30005 6782703631 Charles Deignan Officer common UBS Financial Services Inc

1000 Harbor Blvd 3rd Floor Weehawken NJ 07086

12900 16515 62408866 01/19/2024 Nasdaq common 01/18/2024 RSU vest issuer N 24090 01/18/2024 cash Y 01/19/2024 /s/ UBS Financial Services Inc, as attorney-in-fact for Charles Deignan